النبات
مواضيع عامة في علم النبات
الجذور - السيقان - الأوراق
النباتات الوعائية واللاوعائية
البذور (مغطاة البذور - عاريات البذور)
الطحالب
النباتات الطبية
الحيوان
مواضيع عامة في علم الحيوان
علم التشريح
التنوع الإحيائي
البايلوجيا الخلوية
الأحياء المجهرية
البكتيريا
الفطريات
الطفيليات
الفايروسات
علم الأمراض
الاورام
الامراض الوراثية
الامراض المناعية
الامراض المدارية
اضطرابات الدورة الدموية
مواضيع عامة في علم الامراض
الحشرات
التقانة الإحيائية
مواضيع عامة في التقانة الإحيائية
التقنية الحيوية المكروبية
التقنية الحيوية والميكروبات
الفعاليات الحيوية
وراثة الاحياء المجهرية
تصنيف الاحياء المجهرية
الاحياء المجهرية في الطبيعة
أيض الاجهاد
التقنية الحيوية والبيئة
التقنية الحيوية والطب
التقنية الحيوية والزراعة
التقنية الحيوية والصناعة
التقنية الحيوية والطاقة
البحار والطحالب الصغيرة
عزل البروتين
هندسة الجينات
التقنية الحياتية النانوية
مفاهيم التقنية الحيوية النانوية
التراكيب النانوية والمجاهر المستخدمة في رؤيتها
تصنيع وتخليق المواد النانوية
تطبيقات التقنية النانوية والحيوية النانوية
الرقائق والمتحسسات الحيوية
المصفوفات المجهرية وحاسوب الدنا
اللقاحات
البيئة والتلوث
علم الأجنة
اعضاء التكاثر وتشكل الاعراس
الاخصاب
التشطر
العصيبة وتشكل الجسيدات
تشكل اللواحق الجنينية
تكون المعيدة وظهور الطبقات الجنينية
مقدمة لعلم الاجنة
الأحياء الجزيئي
مواضيع عامة في الاحياء الجزيئي
علم وظائف الأعضاء
الغدد
مواضيع عامة في الغدد
الغدد الصم و هرموناتها
الجسم تحت السريري
الغدة النخامية
الغدة الكظرية
الغدة التناسلية
الغدة الدرقية والجار الدرقية
الغدة البنكرياسية
الغدة الصنوبرية
مواضيع عامة في علم وظائف الاعضاء
الخلية الحيوانية
الجهاز العصبي
أعضاء الحس
الجهاز العضلي
السوائل الجسمية
الجهاز الدوري والليمف
الجهاز التنفسي
الجهاز الهضمي
الجهاز البولي
المضادات الحيوية
مواضيع عامة في المضادات الحيوية
مضادات البكتيريا
مضادات الفطريات
مضادات الطفيليات
مضادات الفايروسات
علم الخلية
الوراثة
الأحياء العامة
المناعة
التحليلات المرضية
الكيمياء الحيوية
مواضيع متنوعة أخرى
الانزيمات
Prions
المؤلف:
Cornelissen, C. N., Harvey, R. A., & Fisher, B. D
المصدر:
Lippincott Illustrated Reviews Microbiology
الجزء والصفحة:
3rd edition , p327-330
2025-09-14
36
After an extensive series of purification procedures, scientists were astonished to find that the infectivity of the agent causing scrapie in sheep was associated with a single protein species, with no detectable associated nucleic acid. This infectious protein is designated the prion protein. It is relatively resistant to proteolytic degradation and, when infectious, tends to form insoluble aggregates of fibrils, similar to the amyloid found in other diseases of the brain.
A. Presence of prion protein in normal mammalian brain
A noninfectious form of PrP, having the same amino acid and gene sequences as the infectious agent, is present in normal mammalian brains on the surface of neurons and glial cells. It is referred to as PrPC (cellular prion protein). Although the function of noninfectious PrPC is unknown, it is highly conserved in nature, with the amino acid and gene sequences differing little among divergent mammalian species. Recent evidence suggests that the wild-type protein participates in signal transduction and/or metal homeostasis. The primary structure and posttranslational modifications of the normal and the infectious forms of the protein are closely related or identical. However, specific mutational changes of single amino acids at a few sites appear to be determinants of susceptibility to exogenous infection and the probability for spontaneous conversion of the nor mal PrPC to the infectious form (PrPSc). The key to becoming infectious apparently lies in the three-dimensional conformation of the PrP. It has been observed that several α-helices present in noninfec tious PrPC are replaced by β-sheets in the infectious form. Presumably, this conformational difference confers relative resistance to proteolytic degradation on infectious prions, thereby distinguishing them from normal PrPC in infected tissue. A model for "reproduction" of the agent is shown in Figure 1.
Fig1. One proposed mechanism for “reproduction” of the infectious prion protein (PrP).
B. Epidemiology
The normal mode of transmission among animals (for example, among sheep in a flock infected with scrapie) has not been elucidated. It is clear, however, that several diseases of domestic animals have been transmitted via feed prepared from other diseased animals.
1. Bovine spongiform encephalopathy: BSE, commonly called mad cow disease, arose in British cattle presumably caused by their feed processed with animal parts prepared from diseased sheep and cattle. The obvious question raised by this occurrence is whether the BSE from infected cattle can be transmitted to humans. Although such a risk was originally considered negligible, a study of infectious material from a cluster of histologically distinctive British CJD cases in unusually young patients (now referred to as “variant,” or vCJD) indicated that animal-to-human transmission very likely did take place. Because the incubation time for symptoms to appear varies from 4 to 40 years, the likelihood of a potential epidemic caused by BSE is unknown.
2. Kuru: An example of human-to-human transmission of a TSE is found in kuru, a disease in which the infectious agent is acquired by an individual’s exposure to diseased brain tissue in the course of ritualistic cannibalism among members of a tribe in New Guinea. Infection occurs by consuming contaminated brain tissue or via inoculation through breaks in the skin following the handling of diseased tissue. With cannibalism cessation in the late 1950s, the disease is disappearing.
3. Creutzfeldt-Jakob disease: Of more general significance are the documented cases of iatrogenic (unintentionally introduced by medical procedures) transmission of CJD, for example, by use of prion-contaminated human pituitary–derived growth hormone pre pared from individuals who died from CJD. In addition, corneal transplants, implantation of contaminated brain electrodes, and blood transfusions have resulted in documented cases of disease transmission. Thus far, there has been no evidence of trans placental transmission or transmission by person-to-person con tact. In about 15 percent of CJD cases, the condition is inherited as a mutation in the PrP gene. However, most CJD cases are sporadic and have an unknown etiology (that is, they occur with no known exposure or mutational change). The incidence of sporadic CJD is low (about 1 to 2 per million population) but in those families with a PrP mutation, an attack rate of 50 to 100 percent is seen in those carrying the mutation. In contrast to CJD, all cases classified as GSS or FFI have involved inheritance of specific PrP mutations. Despite the inherited nature of the disease, brain tis sues from these patients are nevertheless infectious. Knockout mice lacking the gene that encodes PrPC appear normal but are immune to infection with prions.
C. Pathology
Ingestion or other extracerebral exposure to prions results in significant multiplication of prion agents in the follicular dendritic cells within lymphoid tissues and in the spleen, but it is invasion of the central nervous system that results in the typical clinical effects. The basis for the pathogenic consequences of abnormal PrPSc deposition has not been clarified. Diseased brain tissue is characterized by accumulation of abnormal PrPSc in the form of amyloid fibrils in neuron cytoplasmic vesicles (see Figure 2) and in the form of extra cellular amyloid plaques. There is, in addition, extensive vacuolation within neurons, neuronal loss, and astroglial proliferation. The extensive destruction results in the characteristic spongiform appearance of gray matter in histologic sections. Whereas TSE amyloid plaques are morphologically similar to those of Alzheimer disease, the PrP gene is located on a different chromosome than the gene for the Alzheimer amyloid-β-protein precursor, and there is no nucleotide or amino acid homology between the two. Recent evidence suggests that these two proteins may physically interact with one another and participate in the same signaling or transport pathways in neurons.
Fig2. Electron micrograph of fibrillar prion proteins.
D. Clinical significance
TSEs are a group of progressive, ultimately fatal, neurodegenerative diseases affecting humans and a number of animal species. The disease process is fundamentally the same in all TSEs, but their clinical manifestations and histopathologies differ. TSEs also share some similarities with conventional infectious diseases, but their differences are striking (Figure 3).
Fig3. Similarities and differences between conventional and unconventional agents. TSE = Transmissible spongiform encephalopathies. UV = ultraviolet.
1. Molecular basis of inherited TSEs: In each inherited TSE, specific, single amino acid substitutions or insertions of nucleotide repeat sequences are found in the PrP gene. These are thought to increase greatly (106 -fold) the probability of transition to the infectious conformation. In the spontaneously occurring, sporadic disease (that is, with no known exposure to infectious material and no inheritance of a mutated PrP gene), it is proposed that the altered folding occurs randomly with low probability. Importantly, once formed, the abnormal PrPSc acquires both the ability to “multiply,” as well as the properties of an infectious agent. It has been recognized, however, that certain amino acid substitutions at one specific site increase susceptibility to infection.
2. Major symptoms: All TSEs involve deposition of the PrPSc protein. In the inherited forms, each PrPSc mutation is associated with a characteristic clinical phenotype. For example, the most prominent features of CJD are rapidly progressive dementia and behavioral disturbances, ending in death within 1 year. In GSS, ataxia is the more prominent feature, with death resulting in 2 to 6 years. FFI, also fatal within 1 year, has the additional symptom of uncontrollable insomnia. Although there is some difference in age of onset, all human TSEs (with the exception of BSE-associated vCJD) occur relatively late in life, typically between ages 40 and 60 years.
E. Laboratory identification
A presumptive diagnosis can be made on clinical grounds, but there is some overlap with other dementing illnesses. Routine laboratory tests of serum and cerebrospinal fluid are generally normal. The presence of infectious PrPSc in peripheral lymphatic tissue provides specimens for analysis without the need for brain biopsy. Currently, however, definitive diagnosis of these diseases is made by post mortem histopathologic examination of brain sections. Conversion from the wild-type PrPC protein to the abnormal PrPSc is associated with changes in iron homeostasis within the host, leading to the hypothesis that iron-binding proteins could be used as a biomarker for TSE diseases.
F. Treatment and prevention
TSEs are invariably fatal, and no treatment is currently available that can alter this outcome. The unusually high resistance of the infectivity to most disinfecting agents makes transmission prevention by the usual infection control procedures ineffective. Current recommendations for decontamination of a CJD brain specimen are autoclaving at 132oC, plus immersion in either undiluted sodium hypochlorite or 1N sodium hydroxide. With respect to preventing possible transfer of BSE to humans, all animals showing signs of illness are destroyed, and preparation of animal feed from internal organs of potentially infected animals has ceased.
الاكثر قراءة في مواضيع متنوعة أخرى
اخر الاخبار
اخبار العتبة العباسية المقدسة

الآخبار الصحية
